Ambiq Micro, Inc. (AMBQ) - Q2 2025 10-Q Summary
Business Context and Reporting Period
This filing covers the quarterly period ended June 30, 2025. Ambiq Micro, Inc. is a fabless semiconductor company specializing in ultra-low power solutions using its proprietary Sub-threshold Power Optimized Technology (SPOT) platform. The company focuses on edge AI applications for personal devices, medical/healthcare, industrial edge, and smart home markets. As of the filing date, the company is classified as an emerging growth company and a smaller reporting company.
Key Financial Metrics
| Metric | Q2 2025 (3 Months) | Q2 2024 (3 Months) | YTD 2025 (6 Months) | YTD 2024 (6 Months) |
|---|---|---|---|---|
| Net Sales | $17.9 million | $20.3 million | $33.6 million | $35.5 million |
| Gross Profit | $7.2 million | $6.4 million | $15.6 million | $12.6 million |
| Gross Margin | 40.1% | 31.7% | 46.3% | 35.7% |
| Net Loss | $(8.5) million | $(10.6) million | $(16.8) million | $(20.0) million |
| Operating Cash Flow | N/A | N/A | $(10.5) million | $(5.1) million |
| Cash & Equivalents (End of Period) | $47.5 million (as of June 30, 2025) | |||
| Accumulated Deficit | $(337.0) million (as of June 30, 2025) |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 11.7% in Q2 2025 compared to Q2 2024. This was driven by a strategic shift to prioritize non-Mainland China opportunities, resulting in a significant drop in sales to Mainland China (from 42% of sales in Q2 2024 to 12% in Q2 2025).
- Margin Expansion: Despite lower revenue, gross margin improved significantly by 840 basis points in Q2 2025 (40.1% vs. 31.7% prior year). This improvement is attributed to a more favorable product and customer mix outside of Mainland China.
- Expense Management: Operating expenses decreased in Q2 2025 compared to the prior year, with R&D down 5.2% and SG&A down 11.4% (partially due to the absence of a one-time warrant issuance cost in Q2 2024).
- Geographic Shift: Sales to end customers in the United States increased to $14.9 million in Q2 2025 from $11.4 million in Q2 2024, while sales to China dropped to $2.0 million from $8.5 million.
Guidance, Outlook, and Risks
- Recent IPO: Subsequent to the reporting period, on July 31, 2025, the company completed its Initial Public Offering (IPO), raising net proceeds of $97.2 million. All outstanding redeemable convertible preferred stock converted to common stock.
- Liquidity: Management believes cash on hand ($47.5 million pre-IPO) combined with IPO proceeds will fund operations for at least the next 12 months. The company expects to continue incurring losses until it generates significant sales from products currently in development.
- Internal Controls: The company identified a material weakness in internal control over financial reporting related to segregation of duties and IT controls. Remediation efforts are underway, including the implementation of a new financial system.
- Key Risks:
- Customer Concentration: The top 10 end customers accounted for 98% of net sales in the first half of 2025. The largest single customer represented 38% of sales.
- Supply Chain: The company relies on a sole supplier (TSMC) for semiconductor wafers, exposing it to geopolitical risks involving Taiwan and Mainland China.
- Regulatory: Sales to certain customers (e.g., Huawei) are subject to U.S. export controls and license requirements.
Investor Verification Checklist
- Verify the sustainability of the gross margin improvement as the company transitions away from Mainland China customers.
- Monitor the progress of remediation for the identified material weakness in internal controls over financial reporting.
- Assess the impact of the recent IPO on cash runway and the timeline to profitability.
- Review the concentration risk associated with the top 10 customers representing 98% of revenue.
- Confirm the status of export licenses for sales to sanctioned or restricted entities in China.